Benzinga

Benzinga

Benzinga

martes, septiembre 01

Microbot Medical Inc

MBOTNASDAQ
Trade with Public
Trade with Public
$1.49
0.010.68%
al cierre: Aug 28, 5:00 PM EST
$1.50
0.021.35%
Premercado: 5:39 AM EST
Panorámica generalNoticiasPrevisión de beneficiosEventosPrecios objetivoFinanzasSentimientoPropiedadCompararOpcionesInforme de acciones

Microbot Medical Financials

Microbot Medical (MBOT) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Microbot Medical Q2 EPS $(0.08), Inline, Sales $241.000K Miss $340.000K Estimate

Microbot Medical (NASDAQ:MBOT) reported quarterly losses of $(0.08) per share which met the analyst consensus estimate. This is a 20 percent increase over losses of $(0.10) per share from the same period last year. The
Benzinga Newsdesk

PRO
Microbot Medical Q4 EPS $(0.04) Beats $(0.06) Estimate

Microbot Medical (NASDAQ:MBOT) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.06) by 33.33 percent. This is a 78.95 percent increase over losses of $(0.19) per share from
Benzinga Newsdesk

PRO
Microbot Medical Q2 EPS $(0.10) Misses $(0.08) Estimate

Microbot Medical (NASDAQ:MBOT) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate of $(0.08) by 25 percent. This is a 41.18 percent increase over losses of $(0.17) per share from
Benzinga Newsdesk

Microbot Medical Gets Quality Certification for its System

Microbot Medical Inc. (NASDAQ: MBOT) recently announced the receipt of ISO 13485:2016 certification for its quality management system.
Zacks

Dow Dips Over 300 Points; GameStop Shares Spike Higher

Avi Kapoor

Crude Oil Down Over 3%; US Construction Spending Falls In May

Avi Kapoor

Datos y APIs: APIs de Benzinga · API de noticias de acciones · API de calificaciones de analistas · API de logotipos de empresas

Benzinga

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

© 2026 Benzinga | All Rights Reserved